echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Tianjin has launched the project for early diagnosis and treatment of common malignancies in 2020.

    Tianjin has launched the project for early diagnosis and treatment of common malignancies in 2020.

    • Last Update: 2020-08-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Monitoring data show that in 2019, the main cause of death of the household registration population in Tianjin was chronic diseases, of which malignant tumors ranked second in the overall cause of death, and the top five incidence of malignant tumors were lung cancer, thyroid, breast cancer, colorectal cancer and liver cancer. Practice has proved that "early prevention, early detection, early diagnosis and early treatment" is an effective measure to improve the survival rate and reduce mortality of cancer patients, and is the key to cancer prevention and treatment.On the morning of June 10,
    , Tianjin held a start-up and training session on the early diagnosis and treatment of common malignancies in Tianjin in 2020.
    it is understood that, in order to establish a cancer prevention and treatment system and long-term mechanism, since 2017, Tianjin piloted the project of early diagnosis and early treatment of common malignancies, carried out by the Tianjin Cancer Hospital, for more than 150,000 residents of cancer screening, found more than 11,000 high-risk groups, further review of confirmed cancer patients 103 cases. The detection rate of cancer in high-risk population was significantly higher than the incidence of cancer reported by tumor registration, indicating that the early diagnosis and early treatment project in Tianjin has achieved initial results.
    Tianjin will continue to carry out early diagnosis and early treatment of common malignant tumors in the six districts of the city and some streets in Luzhou District on the basis of strict implementation of the normalization of the prevention and control of the new coronary pneumonia epidemic, and is expected to provide free screening for lung cancer, breast cancer, liver cancer and stomach cancer for 21,000 residents aged 40-74. Priority will be given this year to mobilize previously identified high-risk groups for screening, and all residents who participate in screening and are identified as high-risk groups will receive further review free of charge. Residents may register at the primary health care institution where they live and participate in the screening process in accordance with the principle of time-phased appointments. In order to further explore the cancer screening model suitable for the actual situation in Tianjin, residents of some streets (towns) will be selected to conduct imaging examinations and blood index tests in primary health institutions in the district, and women will also undergo mammograms.
    Tianjin Cancer Hospital has comprehensively upgraded the "Tianjin Common Malignant Tumor Joint Screening Registration Platform", which will automatically assess whether residents are high-risk groups according to the results of various screenings, and send timely reminder sMS messages to residents. Residents can scan the two-dimensional code or through the URL login platform to view the results of the initial screening, wherein high-risk groups can apply for appointment review through the platform, review results and further diagnosis and treatment appointments can also be completed through the platform, simplify the screening management process, effectively improve the screening effect.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.